In patients with COVID-19 at risk for severe disease, nirmatrelvir + ritonavir reduced hospitalization or death

Athanasios Vassilopoulos; Eleftherios Mylonakis

doi:10.7326/J22-0038

In patients with COVID-19 at risk for severe disease, nirmatrelvir + ritonavir reduced hospitalization or death

Athanasios Vassilopoulos, Eleftherios Mylonakis

Houston Methodist

Research output: Contribution to journal › Comment/debate › peer-review

9 Scopus citations

Original language	English (US)
Pages (from-to)	JC63
Journal	Annals of Internal Medicine
Volume	175
Issue number	6
DOIs	https://doi.org/10.7326/J22-0038
State	Published - Jun 1 2022

ASJC Scopus subject areas

Internal Medicine

Access to Document

10.7326/J22-0038

Cite this

@article{d10a55651a9241c7b103932d201deedb,

title = "In patients with COVID-19 at risk for severe disease, nirmatrelvir + ritonavir reduced hospitalization or death",

author = "Athanasios Vassilopoulos and Eleftherios Mylonakis",

year = "2022",

month = jun,

day = "1",

doi = "10.7326/J22-0038",

language = "English (US)",

volume = "175",

pages = "JC63",

journal = "Annals of Internal Medicine",

issn = "0003-4819",

publisher = "American College of Physicians",

number = "6",

}

TY - JOUR

T1 - In patients with COVID-19 at risk for severe disease, nirmatrelvir + ritonavir reduced hospitalization or death

AU - Vassilopoulos, Athanasios

AU - Mylonakis, Eleftherios

PY - 2022/6/1

Y1 - 2022/6/1

UR - http://www.scopus.com/inward/record.url?scp=85132454526&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85132454526&partnerID=8YFLogxK

U2 - 10.7326/J22-0038

DO - 10.7326/J22-0038

M3 - Comment/debate

C2 - 35667068

AN - SCOPUS:85132454526

SN - 0003-4819

VL - 175

SP - JC63

JO - Annals of Internal Medicine

JF - Annals of Internal Medicine

IS - 6

ER -

In patients with COVID-19 at risk for severe disease, nirmatrelvir + ritonavir reduced hospitalization or death

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this